Effect of anti-CD3-EGFR bispecific antibody-labeled DCCIK immune cells on proliferation of lung cancer cells
Tropical Journal of Pharmaceutical Research · 25.06.2024 · 23 (5) · 809-813
DOI: 10.4314/tjpr.v23i5.2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tropical Journal of Pharmaceutical Research, online erschienen am 25.06.2024. Verfasst von Minjie Li und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Purpose
To investigate the effect of DC-CIK immune cells labeled with anti-CD3-EGFR bispecific antibody (BSAB) on the proliferation of lung cancer (LC) cells in order to generate data useful for enhancing the therapy of LC.
Methods
The anti-CD3 and anti-EGFR monoclonal antibodies were labeled on the surface of DC-CIK cells using chemical coupling method. Successful preparation of anti-CD3-EGFR BSAB was determined using SDS-PAGE. Two groups of cells were used: labeled group and a DC-CIK group. The cytotoxic effect on A549 LC cells was determined in vitro, and the tumor inhibition capacity was determined in 30 nude mice with LC.
Results
The killing rate of EGFR-positive A549 cells in labeled group was more severe than the killing rate in DC-CIK cells (p < 0.05). Cellular growth rate was significantly lesser in labelled A549 LC cells than in DC-CIK group. After 2 months of treatment, nude mouse tumor size in labeled group was smaller than the tumor volume in DC-CIK group. No obvious adverse reactions (ARs) were observed in both groups.
Conclusion
In vitro, CD3-EGFR BSAB-labeled DC-CIK immune cells produce cytotoxic effect and inhibit the proliferation of LC cells, while in vivo studies reveal that the cells produce good therapeutic effect on LC.
Zitieren
APA
Li, M., & Zhong, Y. (2024). Effect of anti-CD3-EGFR bispecific antibody-labeled DCCIK immune cells on proliferation of lung cancer cells. Tropical Journal of Pharmaceutical Research, 23(5), 809-813. https://doi.org/10.4314/tjpr.v23i5.2
Vancouver
Li M, Zhong Y. Effect of anti-CD3-EGFR bispecific antibody-labeled DCCIK immune cells on proliferation of lung cancer cells. Tropical Journal of Pharmaceutical Research. 2024;23(5):809-813. doi:10.4314/tjpr.v23i5.2
BibTeX
@article{Li2024,
author = {Li, Minjie and Zhong, Yuan},
title = {Effect of anti-CD3-EGFR bispecific antibody-labeled DCCIK immune cells on proliferation of lung cancer cells},
journal = {Tropical Journal of Pharmaceutical Research},
year = {2024},
volume = {23},
number = {5},
pages = {809--813},
doi = {10.4314/tjpr.v23i5.2}
}
EUVIMED